Gelteq (GELS) announced that it has entered into a three year sales agreement with Shenzhen Mana Health Management under which Mana will distribute consumer nutritional products within China using Gelteq’s proprietary gel formulation. The agreement represents a significant step forward in expanding Gelteq’s nutritional product portfolio in China. Under the agreement, Mana will promote, market, and sell a nutritional formulation primarily focused on sugar lowering across China through its multichannel healthcare network. The agreement also includes minimum annual order volumes during its three-year term which Gelteq expects to derive a minimum revenue of approximately USD $1.3 million during the term of the agreement.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GELS:
